Mazzei, CA, Popovski, MA, Kopko, PM. Noninfectious complications of blood transfusion. In: Roback, JD, Grossman, BJ, Harris, T, Hillyer, CD, eds. Technical Manual. 17 ed. Bethesda: AABB; 2011; 727–762.Google Scholar

Sink, BLS. Administration of blood components. In: Roback, JD, Grossman, BJ, Harris, T, Hillyer, CD, eds. Technical Manual. 17 ed. Bethesda: AABB; 2011; 617–629.Google Scholar

Tobian, AA, King, KE, Ness, PM. Transfusion premedications: a growing practice not based on evidence. Transfusion. 2007 Jun; 47(6):1089–1096.Google Scholar

Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2015 [electronic document]. United States Food and Drug Administration Web Site. Available at: www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM518148.pdf. Accessed May 21, 2017.Google Scholar

Lozano, M, Cid, J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfusion Medicine Reviews. 2003 Jan; 17(1):57–68.CrossRefGoogle ScholarPubMed

Valbonesi, M, De Luigi, MC, Lercari, G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. The International Journal of Artificial Organs. 2000 Sep; 23(9):642–646.CrossRefGoogle ScholarPubMed

Hawkins, R. Discrepancy between visual and spectrophotometric assessment of sample haemolysis. Annals of Clinical Biochemistry. 2002 Sep; 39(Pt 5):521–522.CrossRefGoogle ScholarPubMed

National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol Version 2.4 [electronic document]. 2017 January. In: CDC Web Site. Available at: www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf. Accessed May 21, 2017.Google Scholar

Giles, CM. The role of complement in immunohematology. Transfusion. 1989 Nov–Dec; 29(9):803–811.Google Scholar

Tao, MH, Canfield, SM, Morrison, SL. The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain. The Journal of Experimental Medicine. 1991 Apr 1; 173(4):1025–1028.CrossRefGoogle ScholarPubMed

Tormey, CA, Stack, G. The persistence and evanescence of blood group alloantibodies in men. Transfusion. 2009 Mar; 49(3):505–512.Google Scholar

Pineda, AA, Vamvakas, EC, Gorden, LD, Winters, JL, Moore, SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion. 1999 Oct; 39(10):1097–1103.Google Scholar

Vichinsky, EP, Earles, A, Johnson, RA, Hoag, MS, Williams, A, Lubin, B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New England Journal of Medicine. 1990; 322(23):1617–1621.CrossRefGoogle ScholarPubMed

Uhlmann, EJ, Shenoy, S, Goodnough, LT. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion. Transfusion. 2013 May 21. [Epub ahead of print].CrossRefGoogle Scholar

Sowemimo-Coker, SO. Red blood cell hemolysis during processing. Transfusion Medicine Reviews. 2002 Jan; 16(1):46–60.Google Scholar

Shapira, Y, Vaturi, M, Sagie, A. Hemolysis associated with prosthetic heart valves: a review. Cardiology in Review. 2009 May–Jun; 17(3):121–124.Google Scholar

Marti-Carvajal, AJ, Sola, I, Gonzalez, LE, Leon de Gonzalez, G, Rodriguez-Malagon, N. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. The Cochrane Database of Systematic Reviews. 2010(6):CD007539.Google Scholar

Circular of Information: for the Use of Human Blood and Blood Components [electronic document]. Revised November 2013. In: AABB Web Site. Available at: www.aabb.org/tm/coi/Documents/coi1113.pdf. Accessed May 21, 2017.Google Scholar

Andrzejewski, C Jr., Popovsky, MA, Stec, TC, et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Transfusion. 2012 Nov; 52(11):2310–2320.CrossRefGoogle ScholarPubMed

King, KE, Shirey, RS, Thoman, SK, Bensen-Kennedy, D, Tanz, WS, Ness, PM. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2004 Jan; 44(1):25–29.CrossRefGoogle ScholarPubMed

Toy, P, Popovsky, MA, Abraham, E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005; 33(4):721–726.CrossRefGoogle ScholarPubMed

Popovsky, MA, Abel, MD, Moore, SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. The American Review of Respiratory Disease. 1983 Jul; 128(1):185–189.CrossRefGoogle ScholarPubMed

Silliman, CC, Ambruso, DR, Boshkov, LK. Transfusion-related acute lung injury. Blood. 2005 Mar 15; 105(6):2266–2273.Google Scholar

Eder, AF, Herron, R, Strupp, A, et al. Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007 Apr; 47(4):599–607.CrossRefGoogle ScholarPubMed

Toy, P, Gajic, O, Bacchetti, P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012 Feb 16; 119(7):1757–1767.CrossRefGoogle ScholarPubMed

AABB Revises and Clarifies TRALI Risk Reduction Requirements. AABB Weekly Report [serial online]. 2013 Sept 27. Available at: www.aabb.org/resources/publications/weeklyreport/2013/Pages/wr130927.aspx. Accessed February 4, 2014.Google Scholar

Murphy, EL, Kwaan, N, Looney, MR, et al. Risk factors and outcomes in transfusion-associated circulatory overload. The American Journal of Medicine. 2013 Apr; 126(4):357 e329–e338.CrossRefGoogle ScholarPubMed

Popovsky, MA. Pulmonary consequences of transfusion: TRALI and TACO. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis. 2006 Jun; 34(3):243–244.Google ScholarPubMed

Alam, A, Lin, Y, Lima, A, Hansen, M, Callum, JL. The prevention of transfusion-associated circulatory overload. Transfusion Medicine Reviews. 2013 Apr; 27(2):105–112.CrossRefGoogle ScholarPubMed

Pandey, S, Vyas, GN. Adverse effects of plasma transfusion. Transfusion. 2012 May; 52 Suppl 1:65S–79S.Google Scholar

Kopko, PM, Holland, PV. Transfusion-related acute lung injury. British Journal of Haematology. 1999 May; 105(2):322–329.CrossRefGoogle ScholarPubMed

Skeate, RC, Eastlund, T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Current Opinion in Hematology. 2007 Nov; 14(6):682–687.Google Scholar

Li, G, Daniels, CE, Kojicic, M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion. 2009 Jan; 49(1):13–20.Google Scholar

Tobian, AA, Sokoll, LJ, Tisch, DJ, Ness, PM, Shan, H. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion. 2008 Jun; 48(6):1143–1150.Google Scholar

Levy, GJ, Shabot, MM, Hart, ME, Mya, WW, Goldfinger, D. Transfusion-associated noncardiogenic pulmonary edema. Report of a case and a warning regarding treatment. Transfusion. 1986 May–Jun; 26(3):278–281.Google Scholar

Tobian, AA, Savage, WJ, Tisch, DJ, Thoman, S, King, KE, Ness, PM. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion. 2011 Aug; 51(8):1676–1683.Google Scholar

Hirayama, F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. British Journal of Haematology. 2013 Feb; 160(4):434–444.CrossRefGoogle ScholarPubMed

Gilstad, CW. Anaphylactic transfusion reactions. Current Opinion in Hematology. 2003 Nov; 10(6):419–423.CrossRefGoogle ScholarPubMed

Young, C, Chawla, A, Berardi, V, et al. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Transfusion. 2012 Jul; 52(7):1523–1529.CrossRefGoogle ScholarPubMed

Hillyer, CD, Josephson, CD, Blajchman, MA, Vostal, JG, Epstein, JS, Goodman, JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2003:575–589.Google Scholar

Brecher, ME, Means, N, Jere, CS, Heath, D, Rothenberg, S, Stutzman, LC. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion. 2001 Apr; 41(4):477–482.Google Scholar

Murphy, WG, Foley, M, Doherty, C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sanguinis. 2008 Jul; 95(1):13–19.Google Scholar

Pelletier, JP, Transue, S, Snyder, EL. Pathogen inactivation techniques. Best practice & research. Clinical Haematology. 2006; 19(1):205–242.Google Scholar

Snyder, EL, Stramer, S, Benjamin, R. Safety of the blood supply – time to raise the bar. The New England Journal of Medicine. 2015; 372(20):1882–1885.Google Scholar

Seltsam, A, Muller, TH. Update on the use of pathogen-reduced human plasma and platelet concentrates. British Journal of Haematology. 2013 Aug; 162(4):442–454.CrossRefGoogle ScholarPubMed

Anderson, KC, Weinstein, HJ. Transfusion-associated graft-versus-host disease. The New England Journal of Medicine. 1990 Aug 2; 323(5):315–321.Google Scholar

Fast, LD. Developments in the prevention of transfusion-associated graft-versus-host disease. British Journal of Haematology. 2012 Sep; 158(5):563–568.CrossRefGoogle ScholarPubMed

Thuret, I. Post-transfusional iron overload in the haemoglobinopathies. Comptes Rendus Biologies. 2013 Mar; 336(3):164–172.Google Scholar

Sihler, KC, Napolitano, LM. Complications of massive transfusion. Chest. 2010 Jan; 137(1):209–220.CrossRefGoogle ScholarPubMed

Padhi, P, Parihar, GS, Stepp, J, Kaplan, R. Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia. BMJ Case Reports. May 24, 2013. [published online].Google Scholar

Schwartz, J, Winters, JL, Padmanabhan, A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. Journal of Clinical Apheresis. 2013 Jul; 28(3):145–284.CrossRefGoogle Scholar